Viewing StudyNCT00002778



Ignite Creation Date: 2024-05-05 @ 10:23 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00002778
Status: TERMINATED
Last Update Posted: 2011-07-20
First Post: 1999-11-01

Brief Title: Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Organization Data

Organization: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Class: OTHER
Study ID: CDR0000064783
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH